Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 387,000 | 270,000 | 3,613,500 | 0 | 0 |
| Other Working Capital | 114,000 | -29,000 | -354,000 | 0 | 0 |
| Other Operating Activity | 158,000 | 140,000 | 1,954,500 | 0 | 0 |
| Operating Cash Flow | $659,000 | $381,000 | $5,214,000 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -265,000 | -175,000 | -3,030,000 | 0 | 0 |
| Net Acquisitions | -54,000 | 0 | 0 | 0 | 0 |
| Other Investing Activity | 0 | 0 | -183,000 | 0 | 0 |
| Investing Cash Flow | $-319,000 | $-175,000 | $-3,213,000 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -87,000 | -76,000 | -642,000 | 0 | 0 |
| Other Financing Activity | -183,000 | 109,000 | -2,796,000 | 0 | 0 |
| Financing Cash Flow | $-270,000 | $33,000 | $-3,438,000 | $0 | $0 |
| Exchange Rate Effect | 2,000 | 2,000 | 0 | 0 | 0 |
| Beginning Cash Position | 313,000 | 95,000 | 2,789,000 | 0 | 0 |
| End Cash Position | 385,000 | 336,000 | 1,851,000 | 0 | 0 |
| Net Cash Flow | $72,000 | $241,000 | $-938,000 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 659,000 | 381,000 | 5,214,000 | 0 | 0 |
| Free Cash Flow | 659,000 | 381,000 | 5,214,000 | 0 | 0 |